South African Health Products Regulatory Authority withdraws pholcodine-containing medicines from the South African market
The South African Health Products Regulatory Authority - SAHPRA - has made the decision to withdraw pholcodine-containing medicines from the South African market due to the increased risk of sudden, severe, and life-threatening allergic reactions occurring during surgery. Pholcodine has been used as a cough suppressant since the 1950s. It is registered to treat dry coughs and is available in various non-prescription medicines. Sebenzile Nkambule spoke to Mafora Matlala, Pharmacovigilance Manager at Sahpra
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.